A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
iOnctura
iOnctura
Massive Bio, Inc.
BerGenBio ASA
Taproot Health
Haihe Biopharma Co., Ltd.
Deciphera Pharmaceuticals, LLC
Sumitomo Pharma America, Inc.
Fore Biotherapeutics
Celgene
Hoffmann-La Roche
Novartis
INSYS Therapeutics Inc